• Home
  • NEW DAY MEDICINE
  • 7 (57) 2023
  • 22 -7 (57) 2023 — Youldouz Rasoul-Zadeh, Dilfuzaxon Shukurxo’jaeva — NEW ACHIEVEMENTS IN PREDICTING FETAL GROWTH RESTRICTION SYNDROME

22 -7 (57) 2023 — Youldouz Rasoul-Zadeh, Dilfuzaxon Shukurxo’jaeva — NEW ACHIEVEMENTS IN PREDICTING FETAL GROWTH RESTRICTION SYNDROME

NEW ACHIEVEMENTS IN PREDICTING FETAL GROWTH RESTRICTION SYNDROME

Youldouz Rasoul-Zadeh Tashkent Pediatric Medical Institute

Dilfuzaxon Shukurxo’jaeva Tashkent Pediatric Medical Institute

Resume

This review provides an analysis of modern scientific systematic reviews on the problem of some aspects of fetal growth restriction syndrome, the most important of which is the ongoing search for methods for early detection of the risks of developing this pathology. The issues related to the study of the predictive ability of maternal, biochemical, and biophysical markers of fetal growth restriction syndrome, as well as their combined prognostic potential, are considered.

Keywords: pregnancy, first trimester, fetal growth restriction syndrome, markers, ultrasound examination.

First page

125

Last page

129

For citation: Youldouz Rasoul-Zadeh, Dilfuzaxon Shukurxo’jaeva – NEW ACHIEVEMENTS IN PREDICTING FETAL GROWTH RESTRICTION SYNDROME //New Day in Medicine 2023 7(57): 125-129 https://newdaymedicine.com/index.php/2023/07/22/l-266/

LIST OF REFERENCES:

  1. Gruenwald P. “Chronic fetal distress and placental insufficiency,” Neonatology. 1963;5:(3-4):215-265.
  2. Warkany J., Monroe B. B., and Sutherland B., “Intrauterine growth retardation,” The American Journal of Diseases of Children. 1961;102:249-279.
  3. Abraham M., Alramadhan S., Iniguez C., et al., “A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis,” PLoS One. 2017;12(2): Article ID e0170946.
  4. Ding Y.-X. and Cui H., “Integrated analysis of genome-wide DNA methylation and gene expression data provide a regulatory network in intrauterine growth restriction,” Life Sciences. 2017;179:60-65.
  5. Barker D.J., Osmond C., Simmonds S.J., and Wield G.A., “The relation of small head circumference and thinness at birth to death from cardiovascular disease in adult life,” BMJ. 1993;306(6875):422-426.
  6. Brosens I., Pijnenborg R., Vercruysse L., and Romero R., “The great obstetrical syndromes” are associated with disorders of deep placentation,” American Journal of Obstetrics and Gynecology. 2011;204(3):193-201.
  7. Lee A.C., Kozuki N., Cousens S. et al. “Estimates of burden and consequences of infants born small for gestational age in low and middle-income countries with INTERGROWTH-21st standard: analysis of CHERG datasets,” BMJ. 2017;358:article j3677.
  8. World Health Organization, Expert Group on Prematurity World Health Organization, Final report, World Health Organization, Geneva, Switzerland, 1950.
  9. Battaglia F.C. and Lubchenco L.O., “A practical classification of newborn infants by weight and gestational age,” The Journal of Pediatrics. 1967;71(2):159-163.
  10. Mc Cowan L. M., Figueras F., and Anderson N. H., “Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy,” American Journal of Obstetrics and Gynecology. 2018;218(2):S855-S868.
  11. Hughes A.E., Sovio U., Gaccioli F., Cook E., Charnock-Jones D. S., and Smith G.C.S., “The association between first trimester AFP to PA-A ratio and placentally-related adverse pregnancy outcome,” Placenta. 2019;81:25-31.
  12. MacDonald T. M., Tran C., Kaitu’u-Linoetal T. J., “Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks’ gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study,” BMC Pregnancy and Childbirth. 2018;18(1).
  13. Triunfo S., Lobmaier S., Parra-Saavedra M., et al., “Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental under perfusion,” Placenta. 2014;35(6):398-403.
  14. McCowan L. and Horgan R. P., “Risk factors for small for gestational age infants,” Best Practice & Research Clinical Obstetrics & Gynaecology. 2009;23(6):779-793.
  15. McCowan L.M.E., Thompson J.M.D., Taylor R.S. et al., “Clinical prediction in early pregnancy of infants small for gestational age by customized birthweight centiles: findings from a healthy nulliparous cohort,” PLoS One. 2013;8(8):Аrticle ID e70917.
  16. Anderson N.H., Sadler L.C., McKinlay C.J.D., and McCowan L.M.E., “INTERGROWTH-21st vs customized birth weight standards for identification of perinatal mortality and morbidity,” American Journal of Obstetrics and Gynecology. 2016;214(4):509.e1-509.e7.
  17. Bukowski R., Hansen N. I., Willinger M., et al., “Fetal growth and risk of stillbirth: a population-based case-control study,” PLoS Medicine. 2014;11(4):Аrticle e1001633.
  18. Chisholm K.M. and Folkins A.K., “Placental and clinical characteristics of term small-for-gestational-age neonates: a case-control study,” Pediatric and Developmental Pathology. 2016;19(1):37-46.
  19. Lindqvistand P.G., Molin J., “Does antenatal identification of Small-for-gestational-age fetuses significantly improve their outcome?” Ultrasound in Obstetrics and Gynecology. 2005;25(3):258-264.
  20. Graz M.B., Tolsa J.F., and Fumeaux C.J.F., “Being small for gestational age: does it matter for the neurodevelopment of premature infants? A cohort study,” PLoS One. 2015;10(5):Article ID e0125769.

file

download